Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice

Farha Quadri, Maryann Mazer-Amirshahi, Erin R. Fox, Kristy L. Hawley, Jesse M. Pines, Mark S. Zocchi, Larissa S May

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background. Previous studies have described drug shortages; however, there has been no comprehensive evaluation focusing on US antibacterial shortages. Methods. Drug shortage data from the University of Utah Drug Information Service database were analyzed, with a focus on antibacterial agents from 2001 to 2013. We used descriptive statistics to describe trends in drug shortages, analyze drug classes commonly affected, and investigate whether drugs experienced multiple periods of shortages. Results. One hundred forty-eight antibacterial drugs were on shortage over the 13-year study period, with 26 drugs still active on shortage as of December 2013. The median number of new shortages per year was 10 (interquartile range [IQR], 7). The number of drugs on shortage increased at a rate of 0.35 additional drugs every month (95% confidence interval, .22-.49) from July 2007 to December 2013 (P < .001). The median shortage duration was 188 days (IQR, 366.5). Twenty-two percent of drugs experienced multiple shortage periods. Conclusions. There were a substantial number of drug shortages from 2001 to 2013, with a dramatic rise in shortages since 2007. Shortages of agents used to treat multidrug-resistant infections are of concern due to continued transmission and limited treatment options.

Original languageEnglish (US)
Pages (from-to)1737-1742
Number of pages6
JournalClinical Infectious Diseases
Volume60
Issue number12
DOIs
StatePublished - Jun 15 2015
Externally publishedYes

Fingerprint

Pharmaceutical Preparations
Drug Information Services
Databases
Confidence Intervals
Anti-Bacterial Agents
Infection

Keywords

  • Drug shortages
  • National drug codes (NDC)
  • University of Utah drug information service (UUDIS)

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Quadri, F., Mazer-Amirshahi, M., Fox, E. R., Hawley, K. L., Pines, J. M., Zocchi, M. S., & May, L. S. (2015). Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice. Clinical Infectious Diseases, 60(12), 1737-1742. https://doi.org/10.1093/cid/civ201

Antibacterial Drug Shortages From 2001 to 2013 : Implications for Clinical Practice. / Quadri, Farha; Mazer-Amirshahi, Maryann; Fox, Erin R.; Hawley, Kristy L.; Pines, Jesse M.; Zocchi, Mark S.; May, Larissa S.

In: Clinical Infectious Diseases, Vol. 60, No. 12, 15.06.2015, p. 1737-1742.

Research output: Contribution to journalArticle

Quadri, F, Mazer-Amirshahi, M, Fox, ER, Hawley, KL, Pines, JM, Zocchi, MS & May, LS 2015, 'Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice', Clinical Infectious Diseases, vol. 60, no. 12, pp. 1737-1742. https://doi.org/10.1093/cid/civ201
Quadri F, Mazer-Amirshahi M, Fox ER, Hawley KL, Pines JM, Zocchi MS et al. Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice. Clinical Infectious Diseases. 2015 Jun 15;60(12):1737-1742. https://doi.org/10.1093/cid/civ201
Quadri, Farha ; Mazer-Amirshahi, Maryann ; Fox, Erin R. ; Hawley, Kristy L. ; Pines, Jesse M. ; Zocchi, Mark S. ; May, Larissa S. / Antibacterial Drug Shortages From 2001 to 2013 : Implications for Clinical Practice. In: Clinical Infectious Diseases. 2015 ; Vol. 60, No. 12. pp. 1737-1742.
@article{7fb5100759814e7ea979fbc067efaf39,
title = "Antibacterial Drug Shortages From 2001 to 2013: Implications for Clinical Practice",
abstract = "Background. Previous studies have described drug shortages; however, there has been no comprehensive evaluation focusing on US antibacterial shortages. Methods. Drug shortage data from the University of Utah Drug Information Service database were analyzed, with a focus on antibacterial agents from 2001 to 2013. We used descriptive statistics to describe trends in drug shortages, analyze drug classes commonly affected, and investigate whether drugs experienced multiple periods of shortages. Results. One hundred forty-eight antibacterial drugs were on shortage over the 13-year study period, with 26 drugs still active on shortage as of December 2013. The median number of new shortages per year was 10 (interquartile range [IQR], 7). The number of drugs on shortage increased at a rate of 0.35 additional drugs every month (95{\%} confidence interval, .22-.49) from July 2007 to December 2013 (P < .001). The median shortage duration was 188 days (IQR, 366.5). Twenty-two percent of drugs experienced multiple shortage periods. Conclusions. There were a substantial number of drug shortages from 2001 to 2013, with a dramatic rise in shortages since 2007. Shortages of agents used to treat multidrug-resistant infections are of concern due to continued transmission and limited treatment options.",
keywords = "Drug shortages, National drug codes (NDC), University of Utah drug information service (UUDIS)",
author = "Farha Quadri and Maryann Mazer-Amirshahi and Fox, {Erin R.} and Hawley, {Kristy L.} and Pines, {Jesse M.} and Zocchi, {Mark S.} and May, {Larissa S}",
year = "2015",
month = "6",
day = "15",
doi = "10.1093/cid/civ201",
language = "English (US)",
volume = "60",
pages = "1737--1742",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Antibacterial Drug Shortages From 2001 to 2013

T2 - Implications for Clinical Practice

AU - Quadri, Farha

AU - Mazer-Amirshahi, Maryann

AU - Fox, Erin R.

AU - Hawley, Kristy L.

AU - Pines, Jesse M.

AU - Zocchi, Mark S.

AU - May, Larissa S

PY - 2015/6/15

Y1 - 2015/6/15

N2 - Background. Previous studies have described drug shortages; however, there has been no comprehensive evaluation focusing on US antibacterial shortages. Methods. Drug shortage data from the University of Utah Drug Information Service database were analyzed, with a focus on antibacterial agents from 2001 to 2013. We used descriptive statistics to describe trends in drug shortages, analyze drug classes commonly affected, and investigate whether drugs experienced multiple periods of shortages. Results. One hundred forty-eight antibacterial drugs were on shortage over the 13-year study period, with 26 drugs still active on shortage as of December 2013. The median number of new shortages per year was 10 (interquartile range [IQR], 7). The number of drugs on shortage increased at a rate of 0.35 additional drugs every month (95% confidence interval, .22-.49) from July 2007 to December 2013 (P < .001). The median shortage duration was 188 days (IQR, 366.5). Twenty-two percent of drugs experienced multiple shortage periods. Conclusions. There were a substantial number of drug shortages from 2001 to 2013, with a dramatic rise in shortages since 2007. Shortages of agents used to treat multidrug-resistant infections are of concern due to continued transmission and limited treatment options.

AB - Background. Previous studies have described drug shortages; however, there has been no comprehensive evaluation focusing on US antibacterial shortages. Methods. Drug shortage data from the University of Utah Drug Information Service database were analyzed, with a focus on antibacterial agents from 2001 to 2013. We used descriptive statistics to describe trends in drug shortages, analyze drug classes commonly affected, and investigate whether drugs experienced multiple periods of shortages. Results. One hundred forty-eight antibacterial drugs were on shortage over the 13-year study period, with 26 drugs still active on shortage as of December 2013. The median number of new shortages per year was 10 (interquartile range [IQR], 7). The number of drugs on shortage increased at a rate of 0.35 additional drugs every month (95% confidence interval, .22-.49) from July 2007 to December 2013 (P < .001). The median shortage duration was 188 days (IQR, 366.5). Twenty-two percent of drugs experienced multiple shortage periods. Conclusions. There were a substantial number of drug shortages from 2001 to 2013, with a dramatic rise in shortages since 2007. Shortages of agents used to treat multidrug-resistant infections are of concern due to continued transmission and limited treatment options.

KW - Drug shortages

KW - National drug codes (NDC)

KW - University of Utah drug information service (UUDIS)

UR - http://www.scopus.com/inward/record.url?scp=84939517665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939517665&partnerID=8YFLogxK

U2 - 10.1093/cid/civ201

DO - 10.1093/cid/civ201

M3 - Article

C2 - 25908680

AN - SCOPUS:84939517665

VL - 60

SP - 1737

EP - 1742

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 12

ER -